Navigation Links
Malignant tumor or benign cyst?
Date:3/10/2008

The results of a study presented today at the Society of Gynecologic Oncologys 39th Annual Meeting on Womens Cancer offer a promising development on the path toward better management of ovarian cancer. Researchers say testing women suspected of having ovarian cancer for a combination of proteins, or biomarkers in the blood called HE4 and CA 125, could be the key to predicting a womans risk for the disease dubbed the silent killer. Currently there is no adequate diagnostic test for ovarian cancer.

Roughly 20 percent of women will be diagnosed with an ovarian cyst or tumor at some point in their life, and only a small percentage of these women will be diagnosed with ovarian cancer, said Lead Researcher Richard Moore, M.D., assistant professor at The Warren Alpert Medical School of Brown University and a gynecologic oncologist in the Program in Womens Oncology at Women & Infants Hospital of Rhode Island. The problem is that current methods for distinguishing benign ovarian tumors from malignant ones are limited and as a result, women must undergo surgery without an accurate assessment as to their risk for having ovarian cancer prior to their surgery.

Dr. Moore notes that fewer than half of all ovarian cancer patients have their initial surgery performed by a gynecologic oncologist or surgeon with specialized training in the management of ovarian cancer. Our research is aimed at identifying patients at high risk for harboring an ovarian cancer so that they receive the right care from the right physician.

Currently, CA 125 is the only blood test that can be used to help predict a womans risk for ovarian cancer and to help with the clinical management of the disease. However, CA 125 alone lacks the sensitivity required for the detection of ovarian cancer prompting researchers to look at the ability of combinations of biomarkers to predict the presence of ovarian cancer. Earlier this year, Dr. Moore published results of a pilot study in t
'/>"/>

Contact: Stephanie Euler
stephanie@sternassociates.com
908-276-4344 x213
Fujirebio Diagnostics
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
2. iNOS expression may links chronic biliary inflammation to malignant transformation
3. Protein in embryonic stem cells control malignant tumor cells
4. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
5. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Study details regulation of vital tumor suppressor gene p53
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Customized virus kills brain tumor stem cells that drive lethal cancer
10. Study suggests brain tumors need treatment with multiple targeted drugs
11. Bright tumors, dim prospects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... An international team of scientists has shown that more ... treated with existing drugs. , The study found that ... cancers with a genetic mutation that is present in ... JAK inhibitors are currently used, or are in clinical ... and myeloproliferative disorders. , Bowel cancer is the second-most ...
(Date:10/1/2014)... policy focus on expanding access to care for ... to have significant dental disease. In this month,s ... Dental Association , researchers from Tufts University School ... Medicine report on the first large-scale survey to ... caregivers to adults with developmental disabilities. The study ...
(Date:10/1/2014)... Hills, CA (PRWEB) October 01, 2014 ... internationally-franchised Fit Body Boot Camp fitness boot camps, he’s ... selling personal training , with sold out business summits, ... stint as marketing consultant to a recent Spike TV ... Keuilian says that now is the time for personal ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
(Date:10/1/2014)... 01, 2014 Innovations announces the upcoming ... broadcast on Monday, October 20, 2014 at 7:30 a.m. ... will go behind the scenes to learn about Break ... will explore the practical help and information Break the ... the warning signs of abuse, how to navigate the ...
Breaking Medicine News(10 mins):Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... MESA, Calif., March 2 The deadliest wildfires in ... people and injured many more. Local medical institutions are ... with severe burns. The United States, largest tissue bank, ... crisis by providing skin to treat some of those ...
... It is common knowledge that in rich societies the ... every social problem. Likewise, large inequalities of income are ... groundbreaking book, based on 30 years, research, Richard Wilkinson, ... co-author Kate Pickett from the University of York, go ...
... your broccoli: UCLA researchers report that a naturally occurring ... help protect against respiratory inflammation that causes conditions like ... , Published in the March edition of ... that sulforaphane, a chemical in broccoli, triggers an increase ...
... Free Salsa Workouts & MILK in National City Health FairSAN CLEMENTE, ... will get in touch with their Latin side. Sashaying to ... lead to better health. Dancing after all is a form ... - crucial to helping curb health problems like diabetes and obesity ...
... 2 NanoBio Corp. announced today that it will ... milestones in the development of its novel topical treatments ... data will be delivered in five presentations during the ... San Francisco, March 6-9, 2009. In addition to the ...
... GlaxoSmithKline (NYSE: GSK ) is prepared ... (zanamivir) Inhalation Powder ( www.RELENZA.com ) to meet public ... According to newly updated influenza activity data ( http://www.cdc.gov/flu/weekly/ ... Prevention (CDC), the flu virus is widespread in 27 ...
Cached Medicine News:Health News:MTF, Largest Tissue Bank, Provides Skin for Victims of Australian Wildfires 2Health News:Material success and social failure? 2Health News:Broccoli may help protect against respiratory conditions like asthma 2Health News:Drink and Dance Your Way to Health 2Health News:Drink and Dance Your Way to Health 3Health News:NanoBio to Announce Key Clinical and Preclinical Data on Its Topical Anti-infective Lotions at AAD 2009 2Health News:Ample Supplies of Relenza Available as Flu Season Peaks 2Health News:Ample Supplies of Relenza Available as Flu Season Peaks 3
(Date:10/1/2014)... and NEW YORK , October 1, 2014 /PRNewswire/ ... (CRO) and service provider for the medical industries, announced today the ... in New York City . genae Americas was ... is strategically centered in one of the highest concentrations of ... Philippe Kassab , President at genae Americas. "The expansion of ...
(Date:10/1/2014)... , Oct. 1, 2014  Varian Medical Systems (NYSE: ... report results for the fourth quarter of fiscal year ... October 22, 2014.  The news release will be followed ... 2:00 p.m. PT.  The news release and a link ... the company website at: www.varian.com/investor .  To access ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
Breaking Medicine Technology:genae Opens Offices in New York City 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3
... Medical School ,Contributing Editor , ,With over ... breast cancer undoubtedly qualifies as one of Americas ... develop early detection methods and more effective therapy ... true at the molecular level, where discoveries on ...
... located on the short arm of chromosome 6 (6p21.3), is ... HLA region is the human equivalent of the Major Histocompatibility ... that serve as the backbone of antigen presentation. The ... CD8+ T-cells, are expressed by genes located in the HLA-A, ...
Cached Medicine Technology:Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3The Past, Present and Future of HLA Typing 2The Past, Present and Future of HLA Typing 3
... Provides an approach to treatment ... a pressure range to 25 ... to treat patients with severe ... features integrated humidification and built-in ...
... specifically designed for monitoring the performance ... for separation and quantification of cholesterol ... in patient serum samples. Liposure is ... and A (IDL), LDL subfractions, HDL ...
This control is intended for monitoring cell counts in patient cerebrospinal fluid samples, performed manually using a hemocytometer. Spinalscopics is fortified to target levels with purified chemica...
... Ammonia/Alcohol Control is intended ... various ammonia and ethanol assay ... is targeted at clinically significant ... Assay values are provided for ...
Medicine Products: